Management of Post-Hemorrhagic Ventricular Dilatation in the Preterm Infant
Management of Post-Hemorrhagic Ventricular Dilatation in the Preterm Infant is organized by The Pediatrix Center for Research, Education, Quality and Safety (CREQS).
Date & Location:
Friday, February 5, 2021, 8:00 AM - Sunday, February 4, 2024, 11:59 PM
Overview:
Early standardized interventions aiming at cerebral spinal fluid (CSF) and blood removal, based on ventricular measurements, in PHVD, can reduce brain injury and improve neurodevelopmental outcomes. This presentation will address the variability in management of post-hemorrhagic ventricular dilation (PHVD) in the preterm infant, and aim to help providers understand the pathogenesis of PHVD and how it contributes to brain injury and recognize the association of ventricular size with neurodevelopmental outcome Recognize the importance of a standardized approach for early management of PHVD.
ACCME Objectives:
• Discuss the incidence and outcomes of post-hemorrhagic ventricular dilation (PHVD) in the preterm infant.
• Explain the pathogenesis of PHVD and how it contributes to brain injury.
• Summarize the association of ventricular size with neurodevelopmental outcome.
• Describe the importance of a standardized approach for early management of PHVD.
ANCC Learning Outcomes:
• Discuss the incidence and outcomes of post-hemorrhagic ventricular dilation (PHVD) in the preterm infant.
• Explain the pathogenesis of PHVD and how it contributes to brain injury.
• Summarize the association of ventricular size with neurodevelopmental outcome.
• Describe the importance of a standardized approach for early management of PHVD.